About the Study

This study evaluates a new injectable medication to see if it better treats symptoms of schizophrenia. The purpose of the study is to measure the amount of study medication in your blood when you are administered multiple injections of either the study medication or Invega Sustenna. The overnight stays will take place in our Observation Unit. 

Eligibility 

You may be eligible to participate in this study if you:

• are between the ages of 18 – 65 years old
• have been diagnosed with schizophrenia 
• have not received your schizophrenia medication as a shot within the last year
• are not currently taking Risperdal 

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed.

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.